About NBGI Ventures
NBGI Ventures is a venture capital firm founded in 2001. It is primarily based out of London, United Kingdom. As of Feb 2011, NBGI Ventures has invested in 4 companies. It primarily invests in Series A round in United Kingdom based startups. Its investments are spread across Life Sciences sector. Most recently it participated in the $***** Series B round of Cellnovo Overall, NBGI Ventures portfolio has seen 1 acquisition, namely EOS Iamging. A lot of funds co-invest with NBGI Ventures, with names like Stage Capital sharing a substantial percentage of its portfolio.Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, PE & 1 more
Portfolio Acquisitions
Portfolio Soonicorns
NBGI Ventures' List of All Investments
NBGI Ventures has a portfolio of 4 companies. Their most notable investmentis in EOS IamgingTheir portfolio spans across United Kingdom, Denmark and France. They have invested in Life Sciences, across Series A, PE and 1 more. Here is the list of all investments by NBGI Ventures:
Provider of a dialysis system offering multiple kidney therapy modalities. The company offers Dialysis System to provide multiple hemodialysis modalities on a single, convenient platform without the need for traditional bags. This versatility allows healthcare providers to utilize the same system for different clinical requirements.
Key facts about Quanta Dialysis Technologies
- Founded Year: 2008
- Location: Warwick (United Kingdom)
- Annual Revenue: £0 - £1M as on Dec 31, 2024
- Valuation: $*****
- Stage: Series E
- Total Funding till date: $433M
- Employee Count: 135 as on Jul 31, 2026
- Investors: Stage Capital, Monashee Investment Management and 30 Others
- Latest Funding Round: Series E, Nov 18, 2024, $*****
- Highlight: Editors' Pick
2. EOS Iamging
Developer of 2d/3D orthopedic imaging and software solutions. The EOS 2D/3D imaging system is a personalized imaging tool that gives a precise 3D image of the patient's skeleton in the upright position, with a very low radiation dose that can be used to inform all aspects of care.
Key facts about EOS Iamging
- Founded Year: 1989
- Location: Paris (France)
- Stage: Acquired
- Total Funding till date: $43.8M
- Employee Count: 162 as on Jul 31, 2026
- Investors: Herald Investment Management, Smalt Capital and 12 Others
- Latest Funding Round: Post IPO, Jul 17, 2018, $*****
- Highlight: Acquired
Upfront Chromatography is a biotech company that develops and manufactures products and technologies for extraction and recovery of biotherapeutics, functional biomolecules, macromolecular complexes, and even living cells. The company offers its patented technology Rhobust EBA process for high density chromatography adsorbent beads, among others.
Key facts about Upfront Chromatography
- Founded Year: 1992
- Location: Copenhagen (Denmark)
- Annual Revenue: $0 - $1M as on Dec 31, 2014
- Valuation: $*****
- Stage: Series B
- Total Funding till date: $32.3M
- Employee Count: 8 as on Jul 31, 2026
- Investors: Kreos Capital, DSM and 2 Others
- Latest Funding Round: Series B, Jan 15, 2008, $*****
- Highlight: Editors' Pick
4. Cellnovo
CellNovo provides a set of devices for diabetes management - mobile connected micropump, mobile touchscreen controller, blood glucose meter and a mobile app. Patients get to track their exercises with the in-built sensor in micropump, which also senses the influence of activity on blood glucose level; and later delivers the necessary amount of insulin. Patients can also share the recorded information, real-time, with their doctors and family, using the online portal. Attempted an IPO in July'15.
Key facts about Cellnovo
- Founded Year: 2002
- Location: London (United Kingdom)
- Stage: Deadpooled
- Total Funding till date: $48.4M
- Employee Count: 15 as on Apr 30, 2026
- Investors: Advent Life Sciences, Kreos Capital and 12 Others
- Latest Funding Round: Conventional Debt, May 10, 2017, $*****
NBGI Ventures' Investments by Stage
NBGI Ventures has made 2 investments in Series A stage with an average round size of $11.8M, 1 investment in PE stage with an average round size of $18.2M and 1 investment in Series B stage with an average round size of $48.4M.Stage of entry | No. of Investments |
|---|---|
Series A | 2 |
PE | 1 |
Series B | 1 |
Note: We have considered here, only first round of investments
NBGI Ventures' Investments by Sector
NBGI Ventures has a portfolio focused on Life Sciences. Notably, it has invested in 4 Enterprise (B2B) companies, 4 Tech companies, 2 Software companies and at least 2 companies focusing on Tech hardware.NBGI Ventures' Investments by Geography
NBGI Ventures has made most investments in United Kingdom (2), followed by Denmark where it has made 1 investment.Country | No. of Investments |
|---|---|
United Kingdom | 2 |
Denmark | 1 |
France | 1 |
Note: We have considered here, only first round of investments
NBGI Ventures' recent investments
NBGI Ventures has not made any investment in 2026 so far.Here are the most recent investments by NBGI Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Feb 06, 2011 | United Kingdom | Series B | 2992 | [+7] | |
Apr 14, 2010 | France | PE | 2090 | [+3] | |
Sep 17, 2009 | United Kingdom | Series A | 9623 | [+5] | |
Nov 26, 2007 | France | PE | 3602 | [+3] | |
Aug 01, 2007 | Denmark | Series A | 5984 | [+1] |
Acquired companies in NBGI Ventures' Portfolio
1 company from NBGI Ventures' portfolio has been acquired. The most recent acquisition was EOS Iamging in Feb 2020 by ATEC Spine for $*****.Here are NBGI Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Feb 28, 2020 | Nov 26, 2007 | PE | 1481 |
Co-investors of NBGI Ventures
Over the past 19 years, 45 investors have co-invested in NBGI Ventures's portfolio companies. This includes funds and angels.
- Invested before NBGI Ventures: Edmond de Rothschild and Business Angel have invested in rounds before NBGI Ventures. There is 1 company where Edmond de Rothschild has invested before NBGI Ventures and 1 company where Business Angel has invested before NBGI Ventures.
- Top Co-investors of NBGI Ventures: 17 investors entered a company along with NBGI Ventures. These include investors like Stage Capital (2 companies).
- Invested after NBGI Ventures: A total of 26 investors have invested in NBGI Ventures's portfolio after their investments. Top Investors include Air Liquide (1 company), KLSC (1 company) and Merifin Capital (1 company).
